Mark E. Haskins
AstraZeneca (Netherlands)(NL)AstraZeneca (Spain)(ES)University of Virginia(US)
Publications by Year
Research Areas
Lysosomal Storage Disorders Research, Virus-based gene therapy research, Financial Reporting and Valuation Research, Management and Marketing Education, Glycogen Storage Diseases and Myoclonus
Most-Cited Works
- CUSTOMER LIFETIME VALUE, CUSTOMER PROFITABILITY AND THE TREATMENT OF ACQUISITION SPENDING(2005)
- → Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease(1999)205 cited
- → Mechanism of Glycosaminoglycan-Mediated Bone and Joint Disease(2007)204 cited
- → Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs(2002)170 cited
- → Joint and Bone Disease in Mucopolysaccharidoses VI and VII: Identification of New Therapeutic Targets and BioMarkers Using Animal Models(2005)159 cited
- → Large animal models and gene therapy(2005)153 cited
- → Cash Flow in Bankruptcy Prediction(1987)150 cited